Cargando…

Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma

Detalles Bibliográficos
Autores principales: Dal Negro, Roberto W., Bonadiman, Luca, Turco, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058386/
https://www.ncbi.nlm.nih.gov/pubmed/30062011
http://dx.doi.org/10.1186/s40248-018-0144-5
_version_ 1783341683510870016
author Dal Negro, Roberto W.
Bonadiman, Luca
Turco, Paola
author_facet Dal Negro, Roberto W.
Bonadiman, Luca
Turco, Paola
author_sort Dal Negro, Roberto W.
collection PubMed
description
format Online
Article
Text
id pubmed-6058386
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60583862018-07-30 Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma Dal Negro, Roberto W. Bonadiman, Luca Turco, Paola Multidiscip Respir Med Correction BioMed Central 2018-07-24 /pmc/articles/PMC6058386/ /pubmed/30062011 http://dx.doi.org/10.1186/s40248-018-0144-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Correction
Dal Negro, Roberto W.
Bonadiman, Luca
Turco, Paola
Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma
title Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma
title_full Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma
title_fullStr Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma
title_full_unstemmed Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma
title_short Correction to: Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma
title_sort correction to: fluticasone furoate/vilanterol 92/22 μg once-a-day vs beclomethasone dipropionate/formoterol 100/6 μg b.i.d.: a 12-month comparison of outcomes in mild-to-moderate asthma
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058386/
https://www.ncbi.nlm.nih.gov/pubmed/30062011
http://dx.doi.org/10.1186/s40248-018-0144-5
work_keys_str_mv AT dalnegrorobertow correctiontofluticasonefuroatevilanterol9222mgonceadayvsbeclomethasonedipropionateformoterol1006mgbida12monthcomparisonofoutcomesinmildtomoderateasthma
AT bonadimanluca correctiontofluticasonefuroatevilanterol9222mgonceadayvsbeclomethasonedipropionateformoterol1006mgbida12monthcomparisonofoutcomesinmildtomoderateasthma
AT turcopaola correctiontofluticasonefuroatevilanterol9222mgonceadayvsbeclomethasonedipropionateformoterol1006mgbida12monthcomparisonofoutcomesinmildtomoderateasthma